ProQR Announces Webcast of Presentation at Upcoming HC Wainwright Ophthalmology Virtual ConferenceGlobeNewsWire • 08/11/21
ProQR Therapeutics Stock Is Trading Higher On Antisense Oligonucleotide Development PactBenzinga • 05/04/21
ProQR Announces Virtual Presentation of Phase 1/2 Sepofarsen Extension Trial Data at the Association for Research in Vision and Ophthalmology (ARVO) 2021GlobeNewsWire • 04/23/21
ProQR Announces Publication in Nature Medicine for Sepofarsen in Leber Congenital Amaurosis 10GlobeNewsWire • 04/13/21
ProQR Announces Closing of Underwritten Public Offering of Ordinary Shares with Full Exercise of Underwriters' Option to Purchase Additional SharesGlobeNewsWire • 04/05/21
ProQR Announces Virtual Presentation at American Association for Pediatric Ophthalmology and Strabismus (AAPOS) 2021GlobeNewsWire • 04/02/21
ProQR Announces Positive Results from Clinical Trial of QR-421a in Usher Syndrome and Plans to Start Pivotal TrialsGlobeNewsWire • 03/24/21